Carregant...

Second-generation long-acting injectable antipsychotics in schizophrenia: patient functioning and quality of life

Long-acting injectable antipsychotics (LAIs) were developed to make treatment easier, improve adherence, and/or signal the clinician when nonadherence occurs. Second-generation antipsychotic LAIs (SGA-LAIs) combine the advantages of SGA with a long-acting formulation. The purpose of this review is t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuropsychiatr Dis Treat
Autors principals: Montemagni, Cristiana, Frieri, Tiziana, Rocca, Paola
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2016
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4844443/
https://ncbi.nlm.nih.gov/pubmed/27143893
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S88632
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!